Abstract
In-stent restenosis (ISR) is a common adverse event, occurring in 30% of bare metal stents (BMS) and 5-10% of drug-eluting stents (DES). Successful treatment of ISR in ostial and very proximal location in the left circumflex (LCX) artery have been anecdotally reported. We aimed to determine whether
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
